Compounded mometasone formulations prepared per prescriber direction for individualized inflammatory and ENT care plans. Prescription required.
Mometasone is a corticosteroid that may be incorporated into provider-directed care plans when clinically appropriate. HDRx compounds customized mometasone formulations according to individualized prescriber specifications, including strength and dosage form. A valid prescription from a licensed healthcare provider is required.
Compounding allows healthcare providers to tailor corticosteroid preparations for specific patient needs, including nasal, topical, or other delivery routes as directed by the prescriber.
HDRx collaborates with otolaryngology specialists to prepare customized sinus and nasal formulations as part of comprehensive ENT care planning. Learn more about how physicians incorporate compounded therapies in our overview of how ear, nose, and throat specialists use compounded medicines and explore our broader Ear, Nose & Throat medicine page.
Compounded medications are not FDA-approved and are prepared to meet specific patient needs. Patients should consult their licensed healthcare provider to determine whether this formulation is appropriate for their individual condition.
